Evidence map›Paper›PMID 21129961›Full record

ArticleBioorganic & medicinal chemistry letters2011

Modifications of the C6-substituent of penicillin sulfones with the goal of improving inhibitor recognition and efficacy.

Micheal Nottingham, Christopher R Bethel, Sundar Ram Reddy Pagadala, Emily Harry, Abishai Pinto, Zachary A Lemons, Sarah M Drawz, Focco van den Akker, Paul R Carey, Robert A Bonomo and 1 more

Abstract read
In one paragraph

Article in Bioorganic & medicinal chemistry letters, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Methods for Hydroxamic Acid Synthesis.Current organic chemistry · 2019
    Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Micheal NottinghamDepartment of Chemistry, Southern Methodist University, Dallas, TX 75275-0314, USA.
Christopher R Bethel
Sundar Ram Reddy Pagadala
Emily Harry
Abishai Pinto
Zachary A Lemons
Sarah M Drawz
Focco van den Akker
Paul R Carey
Robert A Bonomo
John D Buynak

Funding

MEDICAL SCIENTIST TRAINING PROGRAMT32GM007250 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI HUANG, ALEX YEE-CHEN · 1985 to 2023
$33.4M
Understanding ceftazidime resistance in SHV B-LactamasesR01AI063517 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI BONOMO, ROBERT A. · 2005 to 2023
$4.9M
RAMAN STUDIES OF ENZYME COMPLEXES IN SOLUTION &CRYSTALSR01GM054072 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI CAREY, PAUL R · 1996 to 2013
$3.5M
Mechanistic studies and inhibition strategies for antibiotic resistanceR01AI062968 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI VAN DEN AKKER, FOCCO · 2007 to 2010
$1.1M
Raman Spectroscopic Analysis of Beta-Lactamase Drug InteractionsR56GM054072 · NIGMS · CASE WESTERN RESERVE UNIVERSITY · PI CAREY, PAUL R · 2009 to 2009
$359k
Molecular mechanisms of antibiotic resistanceR56AI062968 · NIAID · CASE WESTERN RESERVE UNIVERSITY · PI VAN DEN AKKER, FOCCO · 2005 to 2005
$270k
NIAID NIH HHS R01 AI062968NIAID NIH HHS R01 AI063517NIAID NIH HHS R01 AI063517-01NIGMS NIH HHS R01 GM054072NIGMS NIH HHS R01 GM54072NIGMS NIH HHS T32 GM007250
6 · The paper itself

Abstract

In order to evaluate the importance of a hydrogen-bond donating substituent in the design of β-lactamase inhibitors, a series of C6-substituted penicillin sulfones, lacking a C2' substituent, and having an sp(3) hybridized C6, was prepared and evaluated against a representative classes A and C β-lactamases. It was found that a C6 hydrogen-bond donor is necessary for good inhibitory activity, but that this feature alone is not sufficient in this series of C6β-substituted penicillin sulfones. Other factors which may impact the potency of the inhibitor include the steric bulk of the C6 substituent (e.g., methicillin sulfone) which may hinder recognition in the class A β-lactamases, and also high similarity to the natural substrates (e.g., penicillin G sulfone) which may render the prospective inhibitor a good substrate of both classes of enzyme. The best inhibitors had non-directional hydrogen-bonding substituents, such as hydroxymethyl, which may allow sufficient conformational flexibility of the acyl-enzyme for abstraction of the C6 proton by E166 (class A), thus promoting isomerization to the β-aminoacrylate as a stabilized acyl-enzyme.

Indexed as

beta-Lactamase Inhibitorsbeta-LactamasesBinding SitesCatalytic DomainComputer SimulationEnzyme InhibitorsPenicillin GPenicillinsProtein Structure, TertiaryStructure-Activity RelationshipSulfonesbeta-Lactamase Inhibitorsbeta-LactamasesEnzyme InhibitorsPenicillin GPenicillinsSulfones

Identifiers

PMID21129961
PMCPMC3167381

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.